Molecular targeting of polo-like kinase 1 (PLK1) for the treatment of brain tumours
Brain cancer is a disease that is difficult to treat and has a high mortality rate. Two of the major challenges facing current treatments are disease relapse and drug resistance. Disease relapse may be attributable to brain tumour initiating cells (BTICs), which are multi-potent stem-like cells en...
| Main Author: | |
|---|---|
| Language: | English |
| Published: |
University of British Columbia
2013
|
| Online Access: | http://hdl.handle.net/2429/44820 |